<DOC>
	<DOCNO>NCT02655939</DOCNO>
	<brief_summary>Reflex plus™ unique blend Collagen Hydrolysate Rosehip extract . The blend contain individual ingredient widely study effectiveness osteoarthritis ( OA ) . Collagen hydrolysate accumulate cartilage help repair OA , relate cartilaginous change . Rosehip work anti-inflammatory pathway thus reduce pain inflammation joint . The two open-label study show effectiveness investigational product OA . The 2 study show specific safety concern consider . The study demonstrate synergistic effect CH Rosehip extract former in-vitro result formulation . The supplement manufacture GMP certify manufacture unit Germany India strict quality control check . Hence , quality supplement batch batch consistency well assure .</brief_summary>
	<brief_title>Study Assess Efficacy Safety Reflex Plus™ Osteoarthritis</brief_title>
	<detailed_description>The purpose study assess effect Reflex Plus osteoarthritis ( OA ) patient . The duration study 12 / 24 week exclude screen period approximate 1 week . The test product study Reflex Plus compose Collagen hydrolysate Rosehip extract , health supplement . It expect help building cartilage efficient joint function relieve pain associate arthritis It help cartilage protection joint pain management.The primary endpoint study change knee pain measure WOMAC osteoarthritis ( OA ) index sum score baseline last visit comparison IP placebo .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Inclusion Criteria Male Female , age ≥ 50 yr ≤ 70 yr , BMI &lt; 30 . WOMAC pain score , 816 scale 0 20 . Diagnosis confirm Gonarthrosis , clinical radiological mean JaegerWirth score ≥2 . Females include study reach menopause . Subjects willing stop restrict supplement medication prior inclusion study even study . Subjects use topical application rescue medication willing stop use 48 hour prior assessment . Subjects Fasting blood glucose level ≤ 140 Systolic blood pressure ≤ 160 mm Hg diastolic blood pressure ≤ 100 mm hg . Subjects willing adhere protocol complete subject diary . Patient willing able provide sign informed consent . Exclusion Criteria Knee pain functional impairment knee joint cause osteoarthritis . Peripheral arterial occlusive disease Acute meniscus injury Rheumatoid Arthritis Infectionassociated arthritis Coxarthrosis Bony injury low extremity ( e.g . femoral neck fracture ) last 12 month Herniated Spinal Disc Any severe organic and/or systemic disease ( e.g . renal , hepatic , cardiovascular ) per investigator 's discretion Known allergy and/or sensitivity ingredient Reflex Plus™ rescue medication Regular intake product may influence study outcome , e.g . : Nutritional Supplement vitamin supplement Mineral product , protein , amino acid concentrate Chondroprotective agent glucosamine sulfate , chondroitin sulfate , gelatin , hyaluronic acid methylsulfonylmethane . Fish oil capsule ( omega 3 fatty acid capsule ) Treatment cartilage protection product last 3 month . Treatment ( oral ingestion injection ) steroidal nonsteroidal antiinflammatory drug exception follow shortacting NSAID : acetylsalicylic acid , diclofenac , ibuprofen , celecoxib ; analgesic e.g . paracetamol , metamizole phenazone . Cortisone treatment within less 3 week prior study inclusion . Intake Opioid analgesic . Intake anticoagulant coumarin type , acenocoumarol phenprocoumon . Simultaneous treatment osteoarthritis knee magnetic therapy , shockwave therapy , acupuncture Smokers exclude study . Occasional smoker willing abstain smoke study consider . History drug alcohol abuse . Simultaneous participation another clinical trial participation within last 6 week .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Gonarthrosis</keyword>
</DOC>